Navigation Links
FFF Enterprises Unveils ‘The 8 Critical Steps to Guaranteed Channel Integrity' at the American Society of Health-System Pharmacists (ASHP) Midyear Meeting in Orlando
Date:12/2/2008

At this year's ASHP midyear meeting, FFF Enterprises, the nation's largest and most trusted distributor of critical-care biopharmaceuticals and vaccines, will unveil its best practices model for supply chain integrity and demonstrate how the company has taken pharmaceutical distribution to a new level. (Booth #1439)

(Vocus) December 2, 2008 -- At this year's ASHP midyear meeting, FFF Enterprises, the nation's largest and most trusted distributor of critical-care biopharmaceuticals and vaccines, will unveil its best practices model for supply chain integrity and demonstrate how the company has taken pharmaceutical distribution to a new level. (Booth #1439)

More than a company that moves product from point A to point B, FFF Enterprises, Inc., the nation’s largest and most trusted distributor of plasma products, vaccines and critical-care biopharmaceuticals, has taken pharmaceutical distribution to a new level. With its "Patients First" philosophy that guides every decision it makes, FFF has made the uncompromising decision to purchase only from the manufacturer and sell only to certified healthcare providers, with 6 additional steps in between, to assure that patients are always the first consideration as products move through its safe channel.

These best practices, which FFF calls The 8 Critical Steps to Guaranteed Channel Integrity™, are crucial to ensuring that patient safety, product efficacy and fair pricing are not compromised anywhere in the supply chain.

Impacting America's pharmaceutical distribution system is precisely what FFF has set as its mission. Having just celebrated its 20th anniversary, and with a perfect safety track record of more than 20 counterfeit-free years, FFF is pleased to unveil The 8 Critical Steps to Guaranteed Channel Integrity at the upcoming ASHP midyear meeting in Orlando, Florida, Dec. 7 – 11, Booth #1439.

"Each step in the 8 steps is critical, it's absolutely essential to the others, to make sure we do not compromise, in any way, patient safety," states Patrick M. Schmidt, chief executive officer, FFF Enterprises. "We are creating a standard for safety and excellence that we hope will continue to have a positive influence on the industry as a whole," he continues.

FFF has clearly set itself apart as an industry leader that goes Beyond Distribution in several ways. Examples include innovative technologies such as the industry's first Verified Electronic Pedigree™ (VEP) system to electronically display the chain of custody for every product that moves through its safe channel, its LotTrack™ service to track products by lot number and provide recall notification to those affected, as well as its MyFluVaccine™ program, which has revolutionized the flu vaccine marketplace.

In addition, FFF provides customers and partners with meaningful communications such as IG Living, the only magazine targeted directly to immune globulin patients and their healthcare providers, its award-winning BioSupply trends e-newsletters, updates, community and flu alerts, and GPO-specific e-newsletters.

FFF's Wow! Customer Care is aptly named, with a responsive, passionate and caring team of knowledgeable professionals that includes customer care representatives, advisors, advocates and a nationwide field team of territory managers to take care of customers needs.

You may visit FFF at ASHP in Orlando at Booth #1439.

About FFF Enterprises, Inc.:
FFF Enterprises, Inc., FFF Enterprises a privately held corporation, is the largest and most trusted distributor of plasma products, vaccines and other biopharmaceuticals in the U.S. Founded in 1988, FFF is celebrating its 20th year with more than a billion dollars in annual sales and a flawless safety track record. FFF's Guaranteed Channel Integrity™ ensures that products are purchased only from the manufacturer and shipped only to healthcare providers, protecting patients and manufacturers from counterfeit risks and pricing irregularities inherent in secondary and gray market channels. FFF’s proprietary technologies, Verified Electronic Pedigree™ and Lot-Track™, provide verification of this secure channel. FFF's MyFluVaccine (www.MyFluVaccine.com) has revolutionized the flu marketplace, offering a dedicated flu vaccine supply, delivered to customers on the date of their choosing, and offering certainty in a volatile market segment. FFF's ability to move rapidly in a dynamically changing marketplace allows the creation of new opportunities for customers through innovative vehicles for distribution.

###

Read the full story at http://www.prweb.com/releases/2008/12/prweb1693544.htm


'/>"/>
Source: PRWeb
Copyright©2008 Vocus, Inc.
All rights reserved  

Related medicine news :

1. Nu Skin Enterprises to Hold 2008 Investor Day
2. Nu Skin Enterprises Names Brett Nelson President of Nu Skin Japan
3. Nu Skin Enterprises Opens the Czech Republic
4. CJPS Enterprises to Increase Focus on Automotive Diversification
5. TrailBlazer Health Enterprises Names New President, Chief Operating Officer
6. Nu Skin Enterprises Reports Third-Quarter 2008 Results
7. Nu Skin Enterprises and Toyo Bio-Pharma Enter Agreement for Joint Product Research and Development
8. Nu Skin Enterprises to Announce Second Quarter 2008 Results
9. Medline Receives Force Majeure Notice From Hong Ray Enterprises
10. Nu Skin Enterprises to Present at Oppenheimer Consumer Growth Conference
11. BME (BioMedical Enterprises, Inc.) Announces U.S. Launch of the Barbed OSStaple(TM) (BOSS) Nitinol Implant
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
FFF Enterprises Unveils ‘The 8 Critical Steps to Guaranteed Channel Integrity' at the American Society of Health-System Pharmacists (ASHP) Midyear Meeting in Orlando
(Date:3/28/2017)... ... March 28, 2017 , ... Award-winning medical group Allied ... as new board chair for Orange County health care system CalOptima Friday. CalOptima ... soon-to-be former chair Mark Refowitz’s term, which runs through June 30 of this ...
(Date:3/28/2017)... San Francisco, CA (PRWEB) , ... March 28, 2017 , ... ... million people suffering from acne, access to quality care can be limited while the ... skincare company that offers customized prescription acne care for every customer online, today released ...
(Date:3/28/2017)... ... , ... The Executives, Staff & Clients of MGE: Management Experts joined forces ... Literacy Campaign at their Semi-Annual Graduation and Fundraiser Event at MGE’s St. Petersburg Office. ... number 14 internationally in literacy. Statistically, a direct relation can be a found between ...
(Date:3/28/2017)... Angeles, CA (PRWEB) , ... March 28, 2017 ... ... credential, which will be offered by the American Association of Integrative Medicine and ... presentations for healthcare providers at the AutismOne 2017 Conference in Colorado Springs. , ...
(Date:3/28/2017)... ... March 28, 2017 , ... ... Camp Conference in Atlantic City March 13-16, was a busy spot this year. ... professional staff discussed strategies for preventing outbreaks among camp communities during the upcoming ...
Breaking Medicine News(10 mins):
(Date:3/28/2017)... CITY, Calif. , March 28, 2017 /PRNewswire/ ... company focused on the development and commercialization of ... pain, announced that the European Medicines Agency (EMA) ... sublingual tablet, 30 mcg) Marketing Authorisation Application (MAA) ... of the MAA is underway. The MAA for ...
(Date:3/28/2017)... 28, 2017  Medeon Biodesign, Inc., a ... pleased to announce that the Company led and ... Orthopedics, Inc., a San Jose, CA ... for orthopedic extremity applications.  The ... primarily due to procedure volume growth, lifestyle influences ...
(Date:3/27/2017)... Israel , March 27, 2017 ... THXBY), a specialty clinical-stage pharmaceutical company specializing in the development ... its public offering in the United ... (ADSs), each ADS representing 40 ordinary shares of ... ADS. In addition, Therapix has granted the underwriters ...
Breaking Medicine Technology: